BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17937814)

  • 1. Molecular signatures define two main classes of meningiomas.
    Carvalho LH; Smirnov I; Baia GS; Modrusan Z; Smith JS; Jun P; Costello JF; McDermott MW; Vandenberg SR; Lal A
    Mol Cancer; 2007 Oct; 6():64. PubMed ID: 17937814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative genomic hybridization analysis of genomic alterations in benign, atypical and anaplastic meningiomas.
    Arslantas A; Artan S; Oner U; Durmaz R; Müslümanoğlu H; Atasoy MA; Başaran N; Tel E
    Acta Neurol Belg; 2002 Jun; 102(2):53-62. PubMed ID: 12161900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative proteomic profiles of meningioma subtypes.
    Okamoto H; Li J; Vortmeyer AO; Jaffe H; Lee YS; Gläsker S; Sohn TS; Zeng W; Ikejiri B; Proescholdt MA; Mayer C; Weil RJ; Oldfield EH; Zhuang Z
    Cancer Res; 2006 Oct; 66(20):10199-204. PubMed ID: 17047085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative genomic hybridization analysis of genetic alterations associated with malignant progression of meningioma.
    Ozaki S; Nishizaki T; Ito H; Sasaki K
    J Neurooncol; 1999 Jan; 41(2):167-74. PubMed ID: 10222437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of chromosomal imbalances in spinal meningiomas by comparative genomic hybridization.
    Arslantas A; Artan S; Oner U; Durmaz R; Müslümanoglu H; Atasoy MA; Başaran N; Tel E
    Neurol Med Chir (Tokyo); 2003 Jan; 43(1):12-8; discussion 19. PubMed ID: 12568317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microarray-based gene expression profiling of benign, atypical and anaplastic meningiomas identifies novel genes associated with meningioma progression.
    Wrobel G; Roerig P; Kokocinski F; Neben K; Hahn M; Reifenberger G; Lichter P
    Int J Cancer; 2005 Mar; 114(2):249-56. PubMed ID: 15540215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of histopathologic classification with proliferative activity and DNA ploidy in 120 intracranial meningiomas, with special reference to atypical meningioma.
    Myong NH; Chi JG
    J Korean Med Sci; 1997 Jun; 12(3):221-7. PubMed ID: 9250918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple Whole Chromosomal Gains Define Angiomatous Meningiomas and Are Absent From the Tumor Vasculature.
    Ahrendsen JT; Hsu N; Wolf Z; Bryke C; Varma H
    J Neuropathol Exp Neurol; 2020 Jun; 79(6):618-625. PubMed ID: 32357369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic and transcriptome analysis revealing an oncogenic functional module in meningiomas.
    Chang X; Shi L; Gao F; Russin J; Zeng L; He S; Chen TC; Giannotta SL; Weisenberger DJ; Zada G; Wang K; Mack WJ
    Neurosurg Focus; 2013 Dec; 35(6):E3. PubMed ID: 24289128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microarray gene expression profiling in meningiomas: differential expression according to grade or histopathological subtype.
    Fèvre-Montange M; Champier J; Durand A; Wierinckx A; Honnorat J; Guyotat J; Jouvet A
    Int J Oncol; 2009 Dec; 35(6):1395-407. PubMed ID: 19885562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1p and 3p deletions in meningiomas without detectable aberrations of chromosome 22 identified by comparative genomic hybridization.
    Carlson KM; Bruder C; Nordenskjöld M; Dumanski JP
    Genes Chromosomes Cancer; 1997 Dec; 20(4):419-24. PubMed ID: 9408760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of HER2/neu in meningiomas: an immunohistochemistry and fluorescence in situ hybridization study].
    Wang CL; Mei JH; Wang SS; Xu S; Xu LL; Xiong YF
    Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):156-60. PubMed ID: 20450760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression profiling analyses identifies downregulation of 1p, 6q, and 14q genes and overexpression of 6p histone cluster 1 genes as markers of recurrence in meningiomas.
    Pérez-Magán E; Rodríguez de Lope A; Ribalta T; Ruano Y; Campos-Martín Y; Pérez-Bautista G; García JF; García-Claver A; Fiaño C; Hernández-Moneo JL; Mollejo M; Meléndez B
    Neuro Oncol; 2010 Dec; 12(12):1278-90. PubMed ID: 20685720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas.
    Amatya VJ; Takeshima Y; Sugiyama K; Kurisu K; Nishisaka T; Fukuhara T; Inai K
    Hum Pathol; 2001 Sep; 32(9):970-5. PubMed ID: 11567227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?
    Sayagués JM; Tabernero MD; Maíllo A; Espinosa A; Rasillo A; Díaz P; Ciudad J; López A; Merino M; Gonçalves JM; Santos-Briz A; Morales F; Orfao A
    J Mol Diagn; 2004 Nov; 6(4):316-25. PubMed ID: 15507670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosomal losses and gains in meningiomas: comparative genomic hybridization (CGH) study of the whole genome.
    Maruno M; Yoshimine T; Muhammad AK; Ninomiya H; Hayakawa T
    Neurol Res; 1998 Oct; 20(7):612-6. PubMed ID: 9785589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
    Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
    Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic landscape of meningiomas.
    Lee Y; Liu J; Patel S; Cloughesy T; Lai A; Farooqi H; Seligson D; Dong J; Liau L; Becker D; Mischel P; Shams S; Nelson S
    Brain Pathol; 2010 Jul; 20(4):751-62. PubMed ID: 20015288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High resolution genomic profiling and classical cytogenetics in a group of benign and atypical meningiomas.
    Holland H; Mocker K; Ahnert P; Kirsten H; Hantmann H; Koschny R; Bauer M; Schober R; Scholz M; Meixensberger J; Krupp W
    Cancer Genet; 2011 Oct; 204(10):541-9. PubMed ID: 22137484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for chromosome 9p21 deletions in the malignant progression of meningiomas and the prognosis of anaplastic meningiomas.
    Perry A; Banerjee R; Lohse CM; Kleinschmidt-DeMasters BK; Scheithauer BW
    Brain Pathol; 2002 Apr; 12(2):183-90. PubMed ID: 11958372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.